Next Article in Journal
Metabolomic Analysis of Biochemical Changes in the Serum and Urine of Freund’s Adjuvant-Induced Arthritis in Rats after Treatment with Silkworm Excrement
Next Article in Special Issue
A3, a Scorpion Venom Derived Peptide Analogue with Potent Antimicrobial and Potential Antibiofilm Activity against Clinical Isolates of Multi-Drug Resistant Gram Positive Bacteria
Previous Article in Journal
Insights into Resistance Mechanisms of Inhibitors to Mps1 C604Y Mutation via a Comprehensive Molecular Modeling Study
Previous Article in Special Issue
Cytotoxic, Anti-Proliferative and Apoptosis Activity of l-Amino Acid Oxidase from Malaysian Cryptelytrops purpureomaculatus (CP-LAAO) Venom on Human Colon Cancer Cells
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Mouse β-Defensin 3, A Defensin Inhibitor of Both Its Endogenous and Exogenous Potassium Channels

1
State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan 430072, China
2
Biodrug Research Center, Wuhan University, Wuhan 430072, China
*
Author to whom correspondence should be addressed.
Molecules 2018, 23(6), 1489; https://doi.org/10.3390/molecules23061489
Submission received: 6 May 2018 / Revised: 9 June 2018 / Accepted: 11 June 2018 / Published: 20 June 2018

Abstract

The human defensins are recently discovered to inhibit potassium channels, which are classical targets of the animal toxins. Whether other vertebrate defensins are potassium channel inhibitors remains unknown. In this work, we reported that the mouse β-defensin 3 (mBD3) was a novel inhibitor of both endogenous and exogenous potassium channels. The structural analysis showed that mBD3 is the most identical to human Kv1.3 channel-sensitive human β-defensin 2 (hBD2). However, the pharmacological profiles indicated that the recombinant mBD3 (rmBD3) weakly inhibited the mouse and human Kv1.3 channels. Different from the pharmacological features of human β-defensins, mBD3 more selectively inhibited the mouse Kv1.6 and human KCNQ1/KCNE1 channels with IC50 values of 0.6 ± 0.4 μM and 1.2 ± 0.8 μM, respectively. The site directed mutagenesis experiments indicated that the extracellular pore region of mouse Kv1.6 channel was the interaction site of rmBD3. In addition, the minor effect on the channel conductance-voltage relationship curves implied that mBD3 might bind the extracellular transmembrane helices S1-S2 linker and/or S3-S4 linker of mouse Kv1.6 channel. Together, these findings not only revealed mBD3 as a novel inhibitor of both endogenous and exogenous potassium channels, but also provided a clue to investigate the role of mBD3-Kv1.6 channel interaction in the physiological and pathological field in the future.
Keywords: potassium channel; vertebrate defensin; mouse β-defensin 3; pharmacological feature; mouse Kv1.6 channel; inhibitor potassium channel; vertebrate defensin; mouse β-defensin 3; pharmacological feature; mouse Kv1.6 channel; inhibitor

Share and Cite

MDPI and ACS Style

Zhang, Y.; Zhao, Y.; Liu, H.; Yu, W.; Yang, F.; Li, W.; Cao, Z.; Wu, Y. Mouse β-Defensin 3, A Defensin Inhibitor of Both Its Endogenous and Exogenous Potassium Channels. Molecules 2018, 23, 1489. https://doi.org/10.3390/molecules23061489

AMA Style

Zhang Y, Zhao Y, Liu H, Yu W, Yang F, Li W, Cao Z, Wu Y. Mouse β-Defensin 3, A Defensin Inhibitor of Both Its Endogenous and Exogenous Potassium Channels. Molecules. 2018; 23(6):1489. https://doi.org/10.3390/molecules23061489

Chicago/Turabian Style

Zhang, Yaoyun, Yonghui Zhao, Hongyue Liu, Weiwei Yu, Fan Yang, Wenhua Li, Zhijian Cao, and Yingliang Wu. 2018. "Mouse β-Defensin 3, A Defensin Inhibitor of Both Its Endogenous and Exogenous Potassium Channels" Molecules 23, no. 6: 1489. https://doi.org/10.3390/molecules23061489

APA Style

Zhang, Y., Zhao, Y., Liu, H., Yu, W., Yang, F., Li, W., Cao, Z., & Wu, Y. (2018). Mouse β-Defensin 3, A Defensin Inhibitor of Both Its Endogenous and Exogenous Potassium Channels. Molecules, 23(6), 1489. https://doi.org/10.3390/molecules23061489

Article Metrics

Back to TopTop